Secretin

胰泌素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSecretin
Drug Alias NameSynthetic human secretinSecretin (human)Human SecretinSecretin humanSecreFlo +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSecretin receptor agonists
TargetsSecretin receptor
Therapy Area/IndicationsContrast agentsDiagnostic agentsAutistic Disorder +[10] 
Global Approved IndicationsContrast agentsDiagnostic agentsPancreatic Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/04/09
Country/TerritoryUnited StatesUnited KingdomFinland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChirhoclin Inc
China Registration ClassN/A

Develop Information

Active CompaniesChirhoclin Inc
Inactive CompaniesRepligen CoOrlando Health IncUniversity Of Nottingham +[5] 
Active IndicationsContrast agentsDiagnostic agentsPancreatic Diseases
Inactive IndicationsAutistic DisorderDyspepsiaAbdominal Pain +[7] 

Other Information

ATC CodeV04CK01
Related LinksWikipediaDrugBankKEGG